Vera Therapeutics Inc. (NASDAQ:VERA) is one of the best high short interest stocks with huge upside potential.

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

A liquid supplement is going viral, with wellness influencers claiming it can do everything from clear up skin and curb ...

This abstract caught my attention; it is unusual in that it reports not a trial but a protocol of a trial of homeopathy. I think it deserves a short comment: Cancer-related fatigue (CRF) poses a ...

Europe’s economy is buckling under the pressure of climate regulation. Now the European Commission has signaled it may gradually revise its targets. The industrial math in Germany is unforgiving.

How the placebo effect works is astounding. To learn all about it, click through this gallery.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Panelists discuss how current multiple sclerosis (MS) therapies show limited effectiveness against progression, but emerging ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.